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High glucose inhibits cytosolic calcium signaling in cultured mesangial
cells. Glomerular vasodilatation in the early stages of type 1 diabetes
mellitus apparently results from arteriolar insensitivity to vasoconstric-
tors. Since cytosolic free calcium ([Ca2]1) is a major signaling mecha-
nism for smooth muscle contraction, we studied whether growth of
smooth muscle-like rat glomerular mesangial cells in media with high
glucose concentration affects [Ca211 responses to vasoconstrictors. In
cells grown for five days in 22 m glucose, we observed blunted
responsiveness to three structurally unrelated vasoconstrictors that
elevate [Ca2] via a phospholipase C-dependent mechanism, angioten-
sin II, prostaglandin F2,, and arginine vasopressin. Inhibition of [Ca2i1
responses was not due to an osmotic effect of high glucose, since it was
not mimicked by hypertonic mannitol. While the size of intracellular
Ca2 poois was unaffected by elevated glucose, Na/Ca2 exchange
was markedly inhibited, thus ruling out both impaired filling of Ca2
stores and enhanced counter-regulatory mechanisms. Impaired myo-
inositol transport or intracellular sorbitol accumulation were not re-
sponsible for the effects of high glucose, since supplementation of
media with myo-inositol or with the aldose reductase inhibitor, Alcon
1576, failed to reverse insensitivity to vasoconstrictors. On the other
hand, down-regulation or pharmacological inhibition of protein kinase
C completely reversed the effects of high glucose, thus indicating
involvement of this signal transduction pathway. These data suggest a
possible intracellular mechanism for the impaired vascular sensitivity
underlying early renal hemodynamic changes in diabetes mellitus.
Diabetic glomerulopathy is a typical long-term complication
of insulin-dependent diabetes mellitus. Involvement of the
glomerular mesangium, an intercapillary array of contractile,
smooth muscle-like cells surrounded by amorphous extracellu-
lar matrix, is the hallmark of diabetic glomerulopathy [1, 2].
Hyperfiltration and microalbuminuria in untreated patients or
experimental animals [1, 3] are early signs of glomerular in-
volvement. The harmful potential of increased blood flow and
filtration pressure upon the glomerulus has been demonstrated
by several studies on the hemodynamics of experimental dia-
betes. Blunting hyperfiltration by dietary or pharmacologic
manipulations proved beneficial in preventing or delaying pro-
gression of glomerular lesions [4, 5]. Hyperfiltration results
from a selective decrease of the afferent arteriolar resistances,
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possibly due to reduced sensitivity to vasoconstrictors [3].
Vascular relaxation could be explained by enhanced production
of vasodilators, such as prostaglandins (PG) [6] or atrial natri-
uretic peptides [5]. Alternatively, "distal" insensitivity of the
contractile apparatus of the glomerulus, including mesangial
cells, should be considered [3].
Guzman et al recently reported that high glucose inhibits
cultured rat mesangial cell phosphoinositide metabolism in
response to vasoconstrictor stimuli, such as angiotensin II (Ang
II), arginine vasopressin (AVP), or the thromboxane A2 mi-
metic, U-46619 [7]. Breakdown of inositol-containing phospho-
lipids plays a central role in signal transduction for vasocon-
strictors. In fact, receptor-coupled phospholipase C releases
water-soluble inositol phosphates along with equimolar diacyl-
glycerol (DAG) from membrane phosphoinositides [8]. Inositol
trisphosphate [Ins(l ,4,5)-P3} mobilizes Ca2 from intracellular
stores, resulting in an elevation of cytoplasmic Ca2 concen-
tration ([Ca2]1). The latter is, in turn, a major intracellular
signal for smooth muscle contraction [8, 9]. Recent biochemical
studies have shown that glucose competes with inositol for
transport into the cytoplasm and incorporation into membrane
lipids, that is, phosphoinositides [7]. Additional evidence that
mesangial cell metabolism is profoundly affected by hypergly-
cemia comes from studies of the so-called "polyol pathway",
which indicate that aldose reductase activity is markedly en-
hanced under these conditions [10]. Aldose reductase converts
glucose to sorbitol, which is then transformed to fructose by
sorbitol dehydrogenase. Since enhanced aldose reductase ac-
tivity exceeds that of sorbitol dehydrogenase, intracellular
sorbitol accumulation occurs. Marked elevation of aldose re-
ductase mRNA and protein has been reported in mesangial cells
grown under hyperosmolar conditions [101. The effects of
deranged carbohydrate metabolism on signal transduction for
contractile cells are largely unknown.
In an effort to further clarify the molecular mechanisms of
blunted responsiveness to vasoconstrictors, we have studied
the effects of prolonged exposure to high glucose or hyperos-
molar media on [Ca2] of cultured rat mesangial cells.
Methods
Cell culture
Glomerular explants were grown in culture with standard
techniques to originate pure lines of rat mesangial cells [2, 111.
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Four independent lines, characterized as previously described
[11], were used in passages 3-22. RPMI 1640 medium supple-
mented with 17% heat-inactivated fetal bovine serum (FBS;
Flow Laboratories, Irvine, Scotland, UK), 5 pg/ml human
recombinant insulin (Novo, Copenhagen, Denmark), 10 jsg/ml
ceftriaxone (Hoffmann-La Roche, Base!, Switzerland) was used
for initial plating and maintenance culture. For an experiment,
parallel subcultured dishes were plated in regular complete
RPMI medium and then switched after 24 hours to 5.5 m or 22
m glucose [Dulbecco's Minimum Essential Medium (DMEM);
Paisley, Scotland, UK] supplemented with 17% FBS in the
absence of insulin for five days. In control experiments, man-
nitol was added to 5.5 m medium to bring total osmolality to
values equivalent to 22 m glucose. The cultures were main-
tained at 37°C in a controlled, humidified atmosphere of 95%
02-5% CO2 and subcultured every four to seven days.
[Ca2]1 measurement
[Ca2] was measured fluorometrically in cells loaded with
the intracellular probe, fura-2. After withdrawing FBS for the
24 hours prior to an experiment, confluent monolayers grown
on plastic Aclar coverslips (Allied Engineered Plastics, Potts-
ville, Pennsylvania, USA) were loaded for 40 minutes at 37°C
with 1 M fura-2 in serum-free DMEM, followed by further
incubation for 20 minutes in the same medium without fura-2.
Fluorescence measurements were performed by inserting the
coverslips diagonally in a quartz cuvette filled with 2 ml of
modified Krebs-Henseleit solution of appropriate glucose con-
centration, buffered with 20 mrs N-2-hydroxyethyl-piperazine-
N'-2-ethanesulfonic acid (HEPES) and supplemented with
0.2% fatty acid-free bovine serum albumin. The monolayers
were excited at 340 nm with emission collected at 500 nm in a
Perkin-Elmer LS5B spectrofluorometer equipped with stirrer
and thermostatically controlled cell. Excitation/emission slits
were set at 2.5/5 nm, respectively. Calibration of Ca2-depen-
dent fluorescence was performed by sequential saturation of the
dye with 15 to 40 5M ionomycin (± 10 mM CaCl2) to maximum
fluorescence (Fmax), followed by chelation of Ca2 to minimum
fluorescence (Fmjn) with 7.5 m ethylene glycol-bis (a-amino-
ethyl ether)-N,N,N' ,N'-tetraacetic acid (EGTA) plus 60 mM
Tris, pH 10.5. Ratio fluorometry with alternate 340/380 nm
excitation at 6 second intervals was employed for validation of
each set of experiments. Standard formulae were employed for
the calculation of [Ca2}1, employing a Kd of fura-2 for Ca2 of
224 nM [11—13]. The figures reproduce the original 340 nm
excitation tracings.
Chemicals
lonomycin was from Calbiochem-Behring (La Jolla, Califor-
nia, USA). 4-Bromo-A23187 and fura-2 were from Molecular
Probes (Eugene, Oregon, USA). Alcon 1576 was a gift from
Alcon Co. (Fort Worth, Texas, USA). Mannitol was from Don
Baxter (Trieste, Italy). All other chemicals were of the purest
grade available through Sigma Chemical Company (St. Louis,
Missouri, USA).
Statistical analysis
All data were expressed as mean sa and analyzed by
one-way analysis of variance. Dose-response curves to arginine
vasopressin were analyzed by two-way analysis of variance.
Results
Resting [Ca2}1 of monolayers of cultured rat mesangial cells
was not modified by growth for five days in 22 mri glucose. On
the contrary, the typical [Ca2]1 elevation in response to
addition of vasoconstrictor stimuli of phospholipase C, result-
mg from combined InsP3 mobilization of intracellular Ca2
stores and opening of membrane Ca2 channels, was markedly
inhibited by high glucose (Fig. 1, Table 1). Three structurally
unrelated agents, angiotensin II (Ang II), PGF2, and arginine
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Fig. 1. Effects of 5.5 (A) and 22 mM (B)
glucose on the [Ca] response to
vasoconstrictors in fura-2-loaded monolayers
of cultured rat mesangial cells. Ang II, 1 M
angiotensin II; PGF2, 1 LM prostaglandin
F2,,; AVP, 0.1 tM arginine vasopressin.
Tracings are representative of N = 10
experiments for each condition.
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Data are mean SE nM [Ca2]1 from N = 10 experiments for each
agent on independent monolayers.
a P < 0.01 vs. 5.5 mM glucose
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vasopressin (AVP) elicited significantly reduced [Ca2]1 tran-
sients in high glucose media as compared to the ordinary culture
conditions. This inhibition of [Ca2] sensitivity to vasocon-
strictors translated into a marked shift of the dose-response
curve to each vasoconstrictor, as graphically illustrated for
AVP in Figure 2. Inhibition of the [Ca2] transient was also
noted after addition of the Ca2 chelator, EGTA (3 mM), to
isolate the component of the [Ca2}1 transient due to discharge
of intracellular stores (not shown).
The effect of glucose was not due to changes of the osmolality
of the culture media or of the bathing solution, since (1)
isoosmotic solutions in which glucose had been replaced by
mannitol failed to elicit such changes (Fig. 3, Table 1), and (2)
acute addition of 22 m glucose to monolayers previously
grown in 5.5 m glucose did not change timing or amplitude of
the [Ca2i response to 0.1 M AVP (540 12 flM vs. 532 26
flM, control vs. acute 22 m glucose, respectively, P= NS on
N = 6 experiments). Additionally, the sudden change in media
osmolality had no effect on basal [Ca2]1 of rat mesangial cells,
indicating that osmotic changes do not activate compensatory
Ca2 fluxes in rat mesangial cells as reported in other cell types
[141.
To understand whether inhibition of the [Ca2] responses to
vasoconstrictors was due to an alteration of the intracellular
Ca2 pools, possibly occurring during growth in high glucose
media, the size of ionophore-releasable Ca2 stores was esti-
mated next. To this end, cells were treated with ionomycin (Fig.
4) in normal media containing 1.25 mM Ca2 (Fig. 4 A and C) or
following chelation of extracellular Ca2 with 3 mM EGTA (Fig.
4 B and D). In the nominal absence of free Ca2, the only
source of ionophore-mobilized Ca2 is represented by intracel-
lular stores, such as cisternae of the endoplasmic reticulum.
Despite substantial inhibition of the Ca2 response to AVP by
high-glucose media (Fig. 4. C vs. A), the Ca2 ionophore
released identical amounts of Ca2 from internal deposits, as
indicated by the percent of Ca2 saturation, obtained by 40 /LM
ionomycin in the presence of 10 mrvi extracellular Ca2. Iden-
tical results were obtained with another Ca2 ionophore, 4-Br-
A23187 (10 LM), which elicited transients averaging 73 21%
and 76 18% of Ca2 saturation in cells grown in 5.5 and 22 mrvt
glucose, respectively. Thus, the amount of releasable Ca2 was
not affected by high glucose growth conditions. We next turned
our attention to another Ca2-regulating mechanism, which in
cultured mesangial cells links [Ca2] to extracellular [Nat],
namely, Na/Ca2 exchange. Activity of this transporter is
demonstrated by a rapid rise of [Ca2]1 upon acute changing of
the Nat-containing bathing solution to a Natfree, isotonic
choline Cl replacement solution. In rat mesangial cell lines,
resting activity of the exchanger is often modest as opposed to
human cells, but prior stimulation of [Ca2J1 with phospholipase
C agonists promptly increases Na/Ca2 exchange [13, 151.
This is illustrated in Figure 5, in which Na was withdrawn
shortly after application of 0.1 M AVP. As apparent from the
comparative tracings, both [Ca2]1 responses to AVP and to
Na removal were markedly inhibited by culture in 22 mM
glucose media. Overall, Na/Ca2 exchange was inhibited by
about 50%, and again a hypertonic mannitol solution failed to
reproduce the effects of glucose, indicating that they were not
mediated by increased osmolality (Table 2).
Table 1. Effect of five-day culture of rat mesangial cells in 5.5/22 mM
glucose media on peak [Ca2) responses to vasoconstrictors 100
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Fig. 3. Effects of 5.5 and 22 m glucose (A) or 22 mw mannitol (B) on
the f Ca2A71 response to 0.1 /.M arginine vasopressin (A VP) in fura-2-
loaded monolayers of cultured rat mesangial cells. Tracings are repre-
sentative of N = 10 experiments for each condition.
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Fig. 2. Effects of 5.5 (•) and 22 (0) mi glucose on the peak [Cdtl,
response to increasing concentrations of arginine vasopressin (A VP) in
fura-2 -loaded monolayers of cultured rat mesangial cells. P < 0,01 vs.
5.5 mss, two-way ANOVA on N = 4 experiments on independent
monoiayers for each concentration.
0 —9 —8 —7
0C
U)0(0
0
U-
U)
C.)C
ci)0
C/)
0
LL
+
C"
Ce0
Fig. 5. Effects of5.5 (A) and 22 mst glucose (B) on Na/Ca2 exchange
in fura-2-loaded monolayers of cultured rat mesangial cells. After
addition of 0.1 ILM arginine vasopressin (AVP) Ca2 entry is promoted
by withdrawal of Na, isoosmotically replaced by choline Cl (Na-
free). Tracings are representative of N = 8 experiments.
Since theoretically both cellular myo-inositol depletion, re-
sulting from competition of high glucose with the myo-inositol
transporter, and intracellular sorbitol accumulation due to
enhanced aldose reductase metabolism could affect Ca2 trans-
port and [Ca2} regulation [7, 10], we treated a group of
monolayers with 22 m glucose for five days in the presence of
excess myo-inositol (400 jLM vs. 50 jM in conventional media)
or of the aldose reductase inhibitor, Alcon 1576, 14 M. Both
protocols failed to restore the normal [Ca2]1 response to 0.1
LM AVP (control 545 34 nM; + myo-inositol 273 53 nt; +
Alcon 1576 296 20 nri; N = 6, P < 0.01 vs. control). These
results indicate that carbohydrate metabolism derangements,
which have been reported in mesangial cells exposed to exper-
imental hyperglycemia [7, 10], are not responsible for the
[Ca2]1 down-regulatory effects of high glucose.
The effects of glucose on two partially independent [Ca2]
regulating mechanisms, InsP3-mediated Ca2 release from
stores and NaICa2 exchange, are reminiscent of the potent
down-regulatory effects of protein kinase C (PKC) on these
signaling pathways [11, 15]. We then investigated whether PKC
could be involved in the inhibitory effects of high glucose on
[Ca2]1. As shown in Figure 6 A and B, cells grown in 22 m
glucose were treated with the structurally-unrelated PKC inhib-
itors, H-7 and staurosporin, for 10 minutes prior to addition of
AVP. This procedure entirely restored the normal [Ca211
sensitivity of the cells to the vasoconstrictor, thus indicating
that PKC indeed plays a major role in the effects of glucose
(Table 3). Another common procedure for PKC inhibition, that
is, 24 hour exposure to the phorbol ester, phorbol myristate
acetate, also completely restored the peak [Ca2]1 response to
AVP, which is consistent with the experiments employing
chemical inhibitors (Fig. 6C, Table 3).
Discussion
Growth of cultured mesangial cells in media of varying
glucose concentration modulates their phenotype and func-
tional characteristics. Several studies published to date have
emphasized that high glucose enhances matrix formation and
reduces proliferation of mesangial cells in response to serum or
matrix components [16—21]. These effects have been attributed
to either altered mesangial metabolism by glucose itself, or
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Fig. 4. Effects of 5.5 (A, B) and 22 mM
glucose (C, D) on the I Ca'j, response to 0.1
pM arginine vasopressin (A VP) or 40 /SM
ionomycin in fura-2-loaded monolayers of
cultured rat mesangial cells. In A and C,
medium contains 1.25 mat Ca2t In B and D,
3 mM EGTA was added prior to ionomycin to
chelate extracellular Ca2; after removing the
EGTA-containing medium, a 10 mac [Ca21
solution was added to saturate fluorescence to
Fmax (Ca2). Tracings are representative of N
= 6 experiments for each condition.
Table 2. Effect of five-day culture of rat mesangial cells in 5.5/22 mM
glucose media on Na/Ca2 exchange
'1 mm
A AVP 5.5 mr GlucoseNa—FREE
22 m GlucoseB AVP
Na—FREE
484
336
116
147
10978
Condition
Glucose concentration
5.5 mrsi 22 mM
22 mac
glucose +
mannitol
Baseline
Na free
110 15
520 53
114 20278 38 109 34464 66
Data are mean SE nM basal or peak [Ca2'i upon Na replacement
with choline Cl from N = 8 to 9 experiments. Cells were pretreated with
0.1 ILM AVP 3 minutes prior to Na withdrawal to maximally activate
Na/Ca2 exchange.
a P < 0.01 vs. 5.5 m glucose
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Fig. 6. Effects of protein kinase C inhibition
by 0.1 mw H-7 (A), 10 ti staurosporin (B), or
24 hours of pretreatment with 0.1 pi phorbol
myristate acetate (PMA, C) on the [Ca2],
response to 0.1 /LM arginine vasopressin
(AVP) in fura-2 loaded monolayers of cultured
rat mesangial cells grown in 5.5 or 22 mM
glucose media. Tracings are representative of
N = 4 experiments each condition.
Table 3. Reversal of the effects of 22 m glucose on arginine
vasopressin (AVP)-stimulated [Ca2] by protein kinase C inhibition
in monolayers of cultured rat mesangial cells
Condition
Peak [Ca2]1, nM
+ 0.1 ItM AVP
5.5 mii glucose 654 40
22 mM glucose 285 28
22 m glucose + 0.1 mrt H-7 968 154
22 m glucose + 10 M staurosporin 837 45
22 m glucose + 0.1 /LM PMA 736 104
Data are mean SE from N = 4 experiments for each condition.
Abbreviation is: PMA, phorbol mynstate acetate (24 hrs preincuba-
tion).
a P < 0.01 vs. 5.5 m glucose.
possibly to the intermediation of glycosylated macromolecules
[18, 19]. Indeed, intracellular sorbitol accumulation, resulting
from enhanced aldose reductase activity, and increased 1,2-
diacyiglycerol (DAG) formation, most likely from de novo
synthesis of excess glucose, have been demonstrated in mesan-
gial cells grown in high glucose media [7, 10, 161. While sorbitol
may interfere with myo-inositol uptake and metabolism, DAG
accumulation results in enhanced PKC activity, as indepen-
dently shown by at least two studies [7, 161. Since PKC
phosphorylates multiple cellular substrates, a wide range of
cellular changes occurring in high glucose environments could
be ascribed to PKC activation [9].
Recently, another line of evidence has supported the concept
of modulation of mesangial cell functional behavior by culture
in high glucose conditions. Guzman et al have described the
inhibitory effects of glucose on agonist-stimulated phospho-
inositide metabolism [7]. Our results on [Ca2]1 regulation are
largely consistent with their finding of blunted InsP formation,
which could theoretically result from receptor down-regulation,
myo-inositol depletion, or G-protein/phospholipase C inhibi-
tion. The observation that the amplitude of the [Ca2] elevation
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in response to several vasoconstrictors is reduced by experi-
mental hyperglycemia is suggestive of reduced mobilization!
entry of Ca2 due to impaired generation of InsP3. The effect
could not be ascribed to depletion of the intracellular Ca2
poois, since ionophores retained identical ability to mobilize
Ca2 in the absence of free extracellular Ca2.
Inasmuch as responses to several unrelated agonists are
similarly inhibited, both in the work by Guzman et al [7] and in
our studies, receptor down-regulation with a decrease of either
number of binding sites or binding affinity are unlikely events.
Nevertheless, a recent preliminary report established that vas-
cular smooth muscle receptors for Ang II and AVP are desen-
sitized by high glucose via a PKC-dependent mechanism [221.
Indeed, variable changes in receptor density for vasoactive
agents have been reported in glomeruli from diabetic rats,
ranging from a decrease to an actual increase of receptor
numbers or affinity [23—25]. Interestingly, we could completely
reverse the inhibitory effects of high glucose within minutes of
the addition of PKC blockers. This time frame appears too
limited to allow for substantial changes of receptor number or
affinity. In fact, a similar approach only partially reversed
receptor down-regulation in the report by Williams, Tsai and
Schrier [221.
The possibility that mesangial cells become depleted of
myo-inositol during prolonged incubation in the presence of
high glucose is indirectly ruled out by the results of our
experiments with myo-inositol supplementation. This is at
variance with the effects of 490 M myo-inositol on InsP
fractional release in the work by Guzman et al, which actually
enhanced the effects of agonists [7]. Such discrepancy may
indicate that blunted InsP mobilization is not the sole mecha-
nism accounting for the effects of high glucose on [Ca2]1.
Previous studies employing sorbinil [7] and our own work with
Alcon 1576, both inhibitors of aldose reductase activity, militate
against the involvement of sorbitol accumulation in down-
regulating mesangial phospholipase C activity. It is likely that
other Ca2 transport pathways are directly involved, as con-
firmed by our observations on high glucose inhibition of Na!
Ca2 exchange. For instance, high glucose has been shown to
depress the activity of voltage-sensitive Ca2 channels in
vascular smooth muscle cells [26]. However, this may not be
the case in cultured mesangial cells, since our experiments in
Ca2-free media showed a similar inhibition of the [Ca2]4
response to vasoconstrictors. Moreover, under most conditions
cultured mesangial cells do not exhibit functional voltage-gated
Ca2 channels [2, 8, 13]. Thus, we turned our attention to the
direct effects of PKC on phospholipase C, since the former
enzyme has been found to potently inhibit [Ca2}1 changes
brought about by vasoconstrictors. Moreover, PKC stimulation
with phorbol esters has been previously found to inhibit the
[Ca2] transient resulting from Na7Ca2 exchange in cells
bathed by Na-free solutions [15]. Previous evidence that PKC
becomes activated during culture in high glucose environment
[7, 16, 22] prompted us to experiment with PKC antagonists to
examine involvement of the enzyme in the [Ca211 inhibitory
response. In keeping with our hypothesis, both H-7 and stau-
rosporin restored normal [Ca2]1 responsiveness, an effect that
could also be duplicated by means of a standard PKC down-
regulation protocol [9, 15].
The inhibitory effects of high glucose could also theoretically
be attributed to osmotic changes due to hypertonic glucose
solutions. However, both the failure of mannitol to duplicate
the effects of high glucose in our studies, and earlier experi-
ments with hyperosmolar substitutes by at least two indepen-
dent groups, point to a biochemical, rather than a physical
effect of glucose [7, 10]. Moreover, our acute experiments with
hypertonic glucose failed to show direct, immediate effects on
[Ca2], thus indicating that, unlike other cell types [14], the
volume-regulatory mechanisms of mesangial cells do not di-
rectly implicate Ca2 transport.
In conclusion, a vast body of studies has identified biochem-
ical adaptations of mesangial cells grown in culture conditions
simulating diabetes mellitus. It is presently difficult to incorpo-
rate all of these data into a coherent model of the pathogenesis
of diabetic glomerulopathy. However, recent findings consis-
tent with receptor/signal transduction down-regulation may
provide a basis for the understanding of reduced vascular
sensitivity to vasoconstrictors in the early stages of renal
involvement. Interpretation of the biochemical mechanisms
underlying glomerular hyperfiltration will be critical to the
development of future pharmacologic approaches to prevention
and treatment of diabetic nephropathy.
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